Rankings
▼
Calendar
IART
Integra LifeSciences Holdings Corporation
$747M
Q2 2018 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$366M
+29.8% YoY
Gross Profit
$229M
62.4% margin
Operating Income
$28M
7.5% margin
Net Income
$11M
3.1% margin
EPS (Diluted)
$0.14
QoQ Revenue Growth
+2.6%
Cash Flow
Operating Cash Flow
$36M
Free Cash Flow
$16M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$3.2B
Total Liabilities
$1.8B
Stockholders' Equity
$1.3B
Cash & Equivalents
$184M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$366M
$282M
+29.8%
Gross Profit
$229M
$183M
+24.8%
Operating Income
$28M
$17M
+62.7%
Net Income
$11M
$11M
+5.0%
Revenue Segments
Codman Specialty Surgical
$240M
65%
Orthopedics and Tissue Technologies
$127M
35%
Geographic Segments
UNITED STATES
$260M
71%
Europe
$51M
14%
Asia Pacific
$35M
10%
Rest Of World
$20M
5%
← FY 2018
All Quarters
Q3 2018 →
IART Q2 2018 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena